Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/23832433
Conclusion of this study
This study provides first clinical evidence that curcumin may be used as an effective and safe modality for treatment in patients with MDD without concurrent suicidal ideation or other psychotic disorders.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
